Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults

NCT07385287 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria (Plasmodium Falciparum)

Interventions

BIOLOGICAL: Genetically attenuated PfSPZ Vaccine
OTHER: Normal Saline (0.9% Sodium Chloride)

Sponsor

Sanaria Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]